<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-216 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-216</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-216</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-7.html">extraction-schema-7</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <p><strong>Paper ID:</strong> paper-0ea4b140bbc8fabc484ee21c11f398aba1f9b9b3</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/0ea4b140bbc8fabc484ee21c11f398aba1f9b9b3" target="_blank">Metastatic colonization by circulating tumour cells</a></p>
                <p><strong>Paper Venue:</strong> Nature</p>
                <p><strong>Paper TL;DR:</strong> An improved understanding of the mechanistic determinants of such colonization is needed to better prevent and treat metastatic cancer.</p>
                <p><strong>Cost:</strong> 0.022</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e216.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e216.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Breast->Lung</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Breast carcinoma metastasis to the lung</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Breast cancer commonly seeds the lung; lung colonization is promoted by cancer-cell autonomous extravasation programs, stromal-priming (TGF-β) and tumour-derived niche components that amplify stem-cell pathways.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genes that mediate breast cancer metastasis to lung</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>breast cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>lung</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Combination of hemodynamic entrapment in the pulmonary capillary bed, cancer-cell extravasation programs (invadopodia/motility), and pre- or ad-hoc niche formation that amplifies stem-cell signalling (seed-and-soil with multiple parallel mediators).</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Fascin-1 and invadopodia components; autocrine motility enhancers epiregulin and WNT ligands; expression of ANGPTL4 (TGF-β induced), VEGF, COX2, MMP1, osteonectin; tumour-derived tenascin C and periostin that amplify Notch/Wnt signalling.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Pulmonary capillary architecture (tight endothelium and basement membrane) that requires active extravasation; stromal chemotactic and matrix-remodelling signals induced by tumour systemic factors; local matrix components that can be co-opted (tenascin C deposition).</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Genetic screens and experimental metastasis models identified lung metastasis mediators (Minn et al., 2005). Padua et al. showed TGF-β induces ANGPTL4 in breast tumour cells to promote lung seeding; Oskarsson et al. demonstrated breast cancer cells deposit tenascin C in incipient lung colonies to amplify Notch/Wnt and support outgrowth in mouse models.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Targeting pathways that mediate extravasation or niche-support (e.g. TGF-β–ANGPTL4 axis, Wnt/Notch signalling, ECM remodeling) could limit lung colonization; no specific approved organ-directed anti-metastasis therapy cited for lung in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Circulatory patterns (first capillary bed = lung) increase initial retention; CTC cluster composition, platelet coating, and pre-metastatic niche signals increase probability of seeding.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e216.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Breast->Brain</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Breast carcinoma metastasis to the brain</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Breast cancer brain metastasis involves specialized extravasation and survival adaptations to breach the blood-brain barrier and resist astrocyte-mediated killing, and reliance on perivascular niche/co-option.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Genes that mediate breast cancer metastasis to the brain</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>breast cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>brain</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Active extravasation across the blood–brain barrier via cancer-cell enzymes and microRNAs, evasion of astrocyte-mediated plasmin/FasL killing by secreting serpins, and perivascular niche vascular co-option mediated by adhesion molecules.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>ST6GalNac5 (sialyltransferase), cathepsin S, microRNAs miR-105 and miR-181c (disrupt endothelial barriers), neuroserpin and serpin B2 (PA inhibitors), L1CAM (mediates vascular co-option).</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Brain capillary specializations (tight endothelium, pericyte/astrocyte reinforcement = blood–brain barrier); astrocyte-derived plasminogen activator that generates plasmin and mobilizes pro-apoptotic FasL.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Bos et al. (2009) identified genes mediating brain metastasis. Valiente et al. (2014) showed brain metastatic cells express serpins to inhibit PA/plasmin-mediated astrocyte killing and promote vascular co-option; Zhou et al. and Tominaga et al. demonstrated tumour-derived miRNAs (miR-105, miR-181c) can disrupt vascular endothelial barriers to promote brain extravasation in model systems; Kienast and colleagues provided real-time imaging of steps in brain metastasis formation.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Mechanisms suggest possible targeting of cancer-cell proteases, microRNA-mediated barrier disruption or adhesion-mediated vascular co-option; review notes urgent need for better understanding and therapies for brain metastasis but does not list successful brain-specific therapies.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Blood–brain barrier anatomical resistance makes brain infiltration inefficient; immune and non-neuronal brain cell interactions (astrocytes, microglia) shape survival.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e216.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Breast->Bone</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Breast carcinoma metastasis to bone (osteolytic)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Breast cancer frequently produces osteolytic bone metastases via cancer cell-driven activation of osteoclastogenesis and a TGF-β–driven vicious cycle that releases bone-derived growth factors.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>A multigenic program mediating breast cancer metastasis to bone</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>breast cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>bone</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Cancer cells secrete factors that stimulate osteoblasts to release RANKL, driving osteoclast maturation and bone resorption; bone matrix degradation releases TGF-β that further stimulates tumour production of osteoclast-activating factors (feed-forward loop).</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Parathyroid hormone–related protein (PTHrP), interleukin-11 (IL-11), TNF-α, MMPs, Jagged1, VCAM-1, sICAM-1; tumour miRNA changes that regulate osteoclasts.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Bone microenvironment with osteoblast/osteoclast coupling and mineralized matrix that releases growth factors (TGF-β) upon resorption; RANKL/osteoprotegerin balance controls osteoclastogenesis.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Kang et al. (2003) defined a multigenic program mediating bone metastasis. Studies show tumour PTHrP, IL-11 and TNF-α cue osteoblasts to release RANKL; MMPs increase RANKL activity and reduce osteoprotegerin; Jagged1/Notch signalling and VCAM-1 mediate osteoclast mobilisation; these mechanisms were supported by experimental mouse models showing osteolytic lesion formation and molecular perturbation experiments referenced in the review.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Anti-resorptive therapies (bisphosphonates) and RANKL inhibition (denosumab) are discussed: adjuvant bisphosphonates reduce bone metastasis and improve survival in postmenopausal women; denosumab reduces fracture incidence in patients on aromatase inhibitors.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Bone provides a niche with permissive survival signals and latent DTC accumulation; immune interactions may also shape latency and outgrowth.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e216.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Prostate->Bone</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Prostate carcinoma metastasis to bone (osteoblastic phenotype)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Prostate cancer shows a strong predilection for bone, often producing osteoblastic lesions by altering the bone remodeling balance toward new bone formation via multiple growth factors and niche occupation.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>prostate cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>bone</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Prostate cancer cells home to and occupy the hematopoietic stem cell niche in bone marrow and secrete factors that stimulate osteoblastic activity, leading to aberrant bone deposition and niche disruption.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Factors implicated include FGFs, IGFs, VEGF, endothelin 1, Wnt ligands and BMPs; niche-occupying behaviour mediated by CXCR4/CXCL12 axis and other homing signals.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Hematopoietic stem cell niches and bone stromal cells that provide supportive signals; osteoblast lineage cells responsive to tumour-derived growth factors leading to osteoblastic bone formation.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Shiozawa et al. (2011) showed human prostate cancer metastases target the HSC niche in mouse bone marrow. Clinical and experimental data cited indicate prostate tumour-derived FGFs/IGFs/VEGF/endothelin/Wnt/BMPs contribute to osteoblastic lesions.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Bone-targeted therapies are relevant (bisphosphonates/denosumab) though osteoblastic lesions are less responsive to anti-resorptives than osteolytic lesions; review suggests targeting niche interactions could be therapeutic but does not specify approved organ-specific approaches for prostate osteoblastic metastasis.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Niche mimicry (occupation of native stem cell niches) and anatomical circulation patterns contribute to establishment.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e216.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Colorectal->Liver</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Colorectal carcinoma metastasis to the liver</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Colorectal cancers preferentially metastasize to the liver due to portal drainage and tumour–stroma interactions in the liver; initiation of metastasis depends on TGF-β–driven stromal programs in some models.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>colorectal cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>liver</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Portal venous drainage increases initial trapping in the liver; successful colonization requires interactions with hepatic stromal cells and a TGF-β–driven stromal program that supplies survival/growth cues.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Colorectal cancer stem cells express factors (e.g., tumour-derived TGF-β in some contexts) that recruit mesenchymal stromal support and induce IL-11 production for Stat3 activation in cancer cells.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Liver sinusoidal vasculature (fenestrated endothelium, discontinuous basal lamina) that facilitates extravasation; hepatic stellate cells and stromal fibroblasts that produce fibronectin and TGF-β–responsive mediators during pre-metastatic conditioning.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Calon et al. (2012) demonstrated dependency of colorectal cancer on a stromal TGF-β program for metastasis initiation in mouse models; clinical observations and circulation anatomy (mesenteric vein → liver) explain the high incidence of hepatic metastasis.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Anatomical drainage routes (portal circulation) and pre-metastatic niche formation by tumour-derived systemic factors (exosomes, cytokines) contribute to liver tropism.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e216.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Colon-liver->Lung</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Secondary colon cancer spread from liver metastases to lung</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Some colon cancers can seed the lung secondarily from established liver metastases, a process driven by p38 MAPK signalling and secreted factors.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>colon cancer (secondary spread)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>lung (from established liver metastases)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Metastasis-to-metastasis seeding where cells from liver metastases acquire signalling (p38 MAPK) and secrete factors (PTHLH) enabling colonization of the lung.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>p38 MAPK pathway activation and PTHLH (parathyroid hormone-like hormone) production by cells in liver metastases.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Lung capillary beds as subsequent receptive sites; not extensively detailed beyond general circulatory access.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Urosevic et al. (2014) reported that KRAS-mutant colon cancer can secondarily colonize the lung from established liver metastases via p38 MAPK signalling and PTHLH in experimental models.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Demonstrates that metastases can seed new metastases (self-seeding/metastasis-to-metastasis), adding complexity to organotropism.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e216.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Melanoma->Various (including liver)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Cutaneous and uveal melanoma metastasis (notably liver in uveal melanoma)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Melanoma shows multi-organ metastasis; uveal melanoma strongly favors the liver. Melanoma cells depend on antioxidant defenses during dissemination and use exosomes to prime distant niches.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>melanoma (cutaneous and uveal mentioned)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>liver (especially uveal melanoma); multiple organs for cutaneous melanoma including lung, brain, liver</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Dependence on antioxidant pathways during transit (resistance to oxidative stress) and systemic pre-metastatic niche formation via tumour-derived exosomes that educate bone marrow progenitors and induce vascular/inflammatory changes.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>NADPH-generating enzymes in the folate pathway (antioxidant defense); exosome cargo including MET and other factors; miRNA networks (Pencheva/Tavazoie references) that regulate secretome and angiogenesis.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Organ-specific responses to exosome cargo (vascular leakiness, inflammation) and organ microenvironments receptive to seeding (e.g., liver microenvironment for uveal melanoma).</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Piskounova et al. (2015) showed oxidative stress inhibits distant metastasis and melanoma cells rely on antioxidant pathways; Le Gal et al. (2015) showed antioxidants can increase melanoma metastasis in mice; Peinado et al. (2012) showed melanoma exosomes educate bone marrow progenitors via MET to promote metastasis in mouse models.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Suggests caution with antioxidant supplementation in melanoma patients and raises the possibility of targeting exosome-mediated niche education; no specific clinical interventions validated in review.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Circulatory trapping, immune surveillance, and organ-specific stromal responses; uveal melanoma has uniquely high liver tropism (mechanism not detailed in this review).</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e216.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Pancreas->Liver</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Pancreatic ductal adenocarcinoma metastasis to the liver</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Pancreatic cancer promotes liver metastasis by releasing exosomes that trigger hepatic stellate cell activation, fibronectin production, TGF-β secretion and recruitment of bone marrow–derived cells to form a pre-metastatic niche.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>pancreatic cancer</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>liver</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Tumour-derived exosomes (containing MIF) prime the liver by inducing TGF-β secretion, fibronectin production by hepatic stellate cells, and recruitment of bone marrow–derived cells, creating a supportive pre-metastatic niche.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Exosomal cargo including macrophage inhibitory factor (MIF) that acts on hepatic cells and stromal components.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Hepatic stellate cells that deposit fibronectin and remodel ECM in response to tumour exosomes; recruited bone marrow–derived cells that provide trophic support.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Costa-Silva et al. (2015) demonstrated in mouse models that pancreatic cancer exosomes containing MIF induce hepatic TGF-β secretion, stellate cell fibronectin production, and mobilize bone marrow–derived cells leading to increased liver metastasis.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td>Targeting exosome production, release, uptake, or specific exosomal cargo could potentially disrupt pre-metastatic niche formation; not yet established clinically.</td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Pre-metastatic niche formation is systemic and can be organ-targeted by exosome integrin signatures (discussed elsewhere in the review).</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.8">
                <h3 class="extraction-instance">Extracted Data Instance 8 (e216.8)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Lung->Brain</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Lung adenocarcinoma metastasis to the brain</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Lung adenocarcinomas frequently relapse in the brain early; brain colonization involves mechanisms similar to other brain-tropic tumours (extravasation factors, astrocyte interactions, endothelin axis).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>lung adenocarcinoma</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>brain</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Active extravasation across the blood–brain barrier, survival via engagement of brain-resident cells (astrocytes/microglia) and chemoprotective signalling such as the endothelin axis.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>Cancer-cell expression of factors that engage endothelin receptors and other mediators that promote chemoprotection in the brain microenvironment.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Brain endothelial/astrocyte barrier properties and astrocyte-derived signals that can be co-opted to protect invading cancer cells.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>The review cites imaging and molecular studies showing brain colonization steps and references Kim et al. (2014) on the endothelin axis mediating astrocyte/endothelial chemoprotection for metastatic breast and lung cancer cells.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Anatomical and temporal patterns: lung cancer often relapses in brain early compared with other tumours; immune surveillance and BBB anatomy are major barriers.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.9">
                <h3 class="extraction-instance">Extracted Data Instance 9 (e216.9)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Sarcoma->Lung</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Sarcoma metastasis to the lung</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Sarcomas preferentially relapse in the lungs, likely reflecting circulatory trapping and the lung capillary bed as the first downstream filter for many primary sites.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>sarcoma</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>lung</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Anatomical/hemodyamic entrapment in pulmonary capillary beds (first downstream microvasculature) leading to high lung retention and subsequent extravasation; organ structural receptivity to growth.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Pulmonary capillary network providing a frequent first filter for circulating tumour cells; lung parenchymal/vascular properties that permit seeding.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Review cites epidemiologic patterns (sarcomas commonly relapse in lungs) and general principles of mechanical entrapment and organ structure but no specific experimental molecular study for sarcoma→lung is detailed in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Circulation patterns and capillary architecture are primary contributors; immune and stromal factors not detailed for sarcoma in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e216.10">
                <h3 class="extraction-instance">Extracted Data Instance 10 (e216.10)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of cancer types and their preferential metastatic sites, including the proposed mechanisms, molecular factors, and experimental evidence for why specific cancers metastasize to specific organs.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Renal->Multiorgan (VHL-HIF)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>VHL-mutant renal cell carcinoma multiorgan metastasis driven by epigenetic expansion of HIF output</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>VHL-mutant renal cell carcinomas gain multiorgan metastatic ability through epigenetic changes that broaden HIF target gene responses, amplifying angiogenic/hypoxia programs important for colonization.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>primary_cancer_type</strong></td>
                            <td>renal cell carcinoma (VHL-mutant)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_site</strong></td>
                            <td>multiple organs (multiorgan metastasis)</td>
                        </tr>
                        <tr>
                            <td><strong>metastatic_frequency</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Epigenetic alterations (DNA methylation, histone acetylation) expand the transcriptional output of the HIF pathway, increasing expression of genes that support metastatic colonization across organs.</td>
                        </tr>
                        <tr>
                            <td><strong>cancer_cell_factors</strong></td>
                            <td>VHL mutation leading to HIF pathway activation; additional DNA methylation and histone acetylation changes that broaden HIF target gene repertoire.</td>
                        </tr>
                        <tr>
                            <td><strong>target_organ_factors</strong></td>
                            <td>Not organ-specific; enhanced HIF output makes cancer cells better able to exploit diverse tissue environments.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_evidence</strong></td>
                            <td>Vanharanta et al. (2013) showed in models that epigenetic remodeling in VHL-mutant renal cell carcinoma expands HIF target gene responses and drives metastasis to multiple organs.</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_evidence</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>therapeutic_implications</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>other_contributing_factors</strong></td>
                            <td>Illustrates that cancer-cell intrinsic epigenetic changes can alter organotropism by increasing adaptability to multiple niches.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Metastatic colonization by circulating tumour cells', 'publication_date_yy_mm': '2016-01'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Genes that mediate breast cancer metastasis to lung <em>(Rating: 2)</em></li>
                <li>Genes that mediate breast cancer metastasis to the brain <em>(Rating: 2)</em></li>
                <li>A multigenic program mediating breast cancer metastasis to bone <em>(Rating: 2)</em></li>
                <li>Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation <em>(Rating: 2)</em></li>
                <li>Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH <em>(Rating: 2)</em></li>
                <li>Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET <em>(Rating: 2)</em></li>
                <li>Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver <em>(Rating: 2)</em></li>
                <li>Serpins promote cancer cell survival and vascular co-option in brain metastasis <em>(Rating: 2)</em></li>
                <li>VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche <em>(Rating: 2)</em></li>
                <li>Oxidative stress inhibits distant metastasis by human melanoma cells <em>(Rating: 2)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>